Journal of Clinical Psychopharmacology · 1995 · 281 citations · 35 references
PharmacyPharmacotherapyPsychiatryNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyPersonality DisordersPsychotherapy For Personality DisordersAntidepressant MedicationsAntidepressant ResponseBorderline Personality TraitsMental Health PharmacotherapyPersonality Disorder TreatmentSelective Serotonin Reuptake Inhibitor TreatmentSelective Serotonin Reuptake Inhibitor UseSubjects
Clinical data and uncontrolled observations have suggested that fluoxetine is helpful in some patients with borderline personality disorder. This article describes the results of a 13-week double-blind study of volunteer subjects with mild to moderately severe borderline personality disorder. Thirteen fluoxetine recipients and nine placebo recipients received treatment. Pretreatment and posttreatment measures were obtained for global mood and functioning, anger, and depression. The most striking finding from this study was a clinically and statistically significant decrease in anger among the fluoxetine recipients. This decrease was independent of changes in depression. These data support previous observations that fluoxetine may reduce anger in patients with borderline personality disorder. The number of subjects in this study was small, the placebo responsiveness was high, and the clinical characteristics of the patients were in the mild to moderate range of severity. The data cannot be extrapolated to more severely ill borderline patients, but further study of fluoxetine and other selective serotonin reuptake inhibitors is indicated in this population.
35
M. Hamilton · Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32.6K citations · Full text
The Medical Journal of Australia · 1962 · 592 citations
Pharmacotherapy of Borderline Personality Disorder
Rex W. Cowdry · Archives of General Psychiatry · 1988 · 475 citations